These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2952299)

  • 1. [Medroxyprogesterone-acetate in gynecologic endocrinology].
    Presl J
    Cesk Gynekol; 1987 Feb; 52(1):60-4. PubMed ID: 2952299
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical considerations on a new estro-progestin combination: ethinylestradiol-medroxyprogesterone acetate].
    Bailo U; Valsecchi A
    Minerva Ginecol; 1965 Sep; 17(17):890-3. PubMed ID: 5852444
    [No Abstract]   [Full Text] [Related]  

  • 3. A comprehensive review of injectable contraception with special emphasis on depot medroxyprogesterone acetate.
    Fraser IS; Weisberg E
    Med J Aust; 1981 Jan; 1(SP1):3-19. PubMed ID: 6453269
    [No Abstract]   [Full Text] [Related]  

  • 4. [Gestagens and the treatment of hot flushes in the postmenopausal period].
    Presl J
    Cesk Gynekol; 1983 Feb; 48(1):47-9. PubMed ID: 6219756
    [No Abstract]   [Full Text] [Related]  

  • 5. [Improvement of climacteric syndrome with MPA treatment (author's transl)].
    Terzi I; Zagami L; Zanno C
    Ann Osp Maria Vittoria Torino; 1980; 23(7-12):447-51. PubMed ID: 6459049
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of medroxyprogesterone acetate and ethinyl estradiol on varied problems associated with the menstrual cycle. A comparison of a combination to a sequential regimen.
    Miyamoto J
    Acta Obstet Gynaecol Jpn; 1970 Oct; 17(4):233-8. PubMed ID: 4249753
    [No Abstract]   [Full Text] [Related]  

  • 7. Perimenopausal patients: treatment with continual escalating-dose synthetic estrogen with added progestogen.
    Roland M; Stubbs S; Ober WB
    Geriatrics; 1972 May; 27(5):138-45. PubMed ID: 5022804
    [No Abstract]   [Full Text] [Related]  

  • 8. Anabolizing and anti-pain effect of the short-term treatment with medroxyprogesterone acetate (MAP) at high oral doses in oncology.
    Pannuti F; Burroni P; Fruet F; Piana E; Strocchi E; Di Marco AR; Cricca A; Camaggi CM
    Panminerva Med; 1980; 22(3):149-56. PubMed ID: 6451859
    [No Abstract]   [Full Text] [Related]  

  • 9. [Depot medroxyprogesterone acetate as contraceptive agent].
    Duarte-Contreras A
    Rev Colomb Obstet Ginecol; 1973; 24(1):13-9. PubMed ID: 4804874
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase II evaluation of oral medroxyprogesterone acetate in advanced breast cancer: a Northern California Oncology Group Study.
    Tan YO; Hendrickson C; McWhirter K; Kohler M; Hannigan JF; Carlson RW
    Cancer Treat Rep; 1987 Oct; 71(10):969-70. PubMed ID: 2958131
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of medroxyprogesterone acetate employed as a long-term injectable contraceptive.
    Ringrose CA
    J Reprod Med; 1972 Feb; 8(2):75-9. PubMed ID: 4666624
    [No Abstract]   [Full Text] [Related]  

  • 12. [Depot medroxyprogesterone acetate: clinical and metabolic effects (lipids, glucose, hemostasis)].
    Hyjazi Y; Maes E; Hurlet A; Masure R; Vekemans M
    J Gynecol Obstet Biol Reprod (Paris); 1985; 14(1):93-103. PubMed ID: 3159786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medroxyprogesterone acetate (MPA) for contraception.
    Sajadi HE; Borazjani G; Ardekany MS
    Int J Fertil; 1972; 17(4):217-20. PubMed ID: 4362389
    [No Abstract]   [Full Text] [Related]  

  • 14. Chromosomal damage induced in human lymphocytes by medroxyprogesterone acetate treatment for precocious puberty.
    Lovell MM; Coco R
    Medicina (B Aires); 1984; 44(2):163-6. PubMed ID: 6242250
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic trial of medroxyprogesterone acetate in severe fibrocystic breast disease].
    Peralta O; Campodónico I
    Rev Chil Obstet Ginecol; 1983; 48(3):146-55. PubMed ID: 6241963
    [No Abstract]   [Full Text] [Related]  

  • 16. Medroxyprogesterone acetate as a contraceptive.
    Hornemann B; Osler M
    Int J Fertil; 1972; 17(4):210-6. PubMed ID: 4362388
    [No Abstract]   [Full Text] [Related]  

  • 17. [Control of fertility by medroxyprogesterone acetate].
    Inglesi JJ; Castro C; de las Mercedes Bondad C; Wahnish EA; Laphitz FB; Piegari N; de Laborde NP; Bergery J; Calio C
    Obstet Ginecol Lat Am; 1974; 32(1-2):57-79. PubMed ID: 4468915
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of oral medroxyprogesterone acetate in the treatment of endometriosis.
    Luciano AA; Turksoy RN; Carleo J
    Obstet Gynecol; 1988 Sep; 72(3 Pt 1):323-7. PubMed ID: 2970029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Depo-Provera--antineoplastic agents which is also a contraceptive].
    Tylleskär J
    Jordemodern; 1988 Mar; 101(3):55-8. PubMed ID: 2967271
    [No Abstract]   [Full Text] [Related]  

  • 20. Medroxprogesterone acetate in the treatment of seizures associated with menstruation.
    Zimmerman AW; Holden KR; Reiter EO; Dekaban AS
    J Pediatr; 1973 Dec; 83(6):959-63. PubMed ID: 4757534
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.